Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05175339 · ClinicalTrials.gov registry record
Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 26
- Enrollment target
NCT05175339: Completed study, sponsored by Johns Hopkins University.
NCT05175339 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05175339 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The Investigator seeks to evaluate the long term neurological and pulmonary sequelae of COVID-19.
Primary Outcome
St. George's Respiratory Questionnaire measures quality of life associated with chronic respiratory diseases. It has been used in various reports of long-term impact of acute respiratory distress syndrome. Scores for each domain range from 0 to 100, with a lower score indicating better pulmonary-specific quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2023-11-13 |
What the finished NCT05175339 record still lists
NCT05175339 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05175339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05175339 about?
NCT05175339 is a clinical study titled "Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)". The Investigator seeks to evaluate the long term neurological and pulmonary sequelae of COVID-19.
What is the current status of trial NCT05175339?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2021-09-29. Estimated completion is 2023-11-13.
Who is sponsoring clinical trial NCT05175339?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI